Alloimmune Thrombocytopenia in the Fetus: Current Management Theories

Journal of Perinatal and Neonatal Nursing

Volumn 17, Issue 3, 2003, Pages 181-189

  Sosa, Mary Ellen Burke ^a  

^a WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

Alloimmune thrombocytopenia; Antiplatelet antibody; Fetal; Human leukocytic antigen (HLA); Human platelet antigen (HPA); Intracranial hemorrhage; Platelet antigen; Platelet transfusion

Indexed keywords

IMMUNOGLOBULIN; THROMBOCYTE ANTIGEN;

ADULT; BLOOD; BRAIN HEMORRHAGE; FEMALE; FETUS DISEASE; HUMAN; IMMUNOLOGY; NEWBORN; NURSING; NURSING METHODOLOGY RESEARCH; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL DEVELOPMENT; PRENATAL DIAGNOSIS; REVIEW; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; UNITED STATES;

ADULT; ANTIGENS, HUMAN PLATELET; CEREBRAL HEMORRHAGE; FEMALE; FETAL DISEASES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; NURSING METHODOLOGY RESEARCH; PLATELET TRANSFUSION; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PRENATAL DIAGNOSIS; THROMBOCYTOPENIA; UNITED STATES;

EID: 0141429973     PISSN: 08932190     EISSN: 15505073     Source Type: Journal    
DOI: 10.1097/00005237-200307000-00003     Document Type: Article

References (29)

1. Murphy M, Williamson L. Antenatal screening for fetomaternal alloimmune thrombocytopenia. Br J Haematol. 2000;111:726-732.
2. Silver R, Porter T, Branch D, et al. Neonatal alloimmune thrombocytopenia: antenatal management. Am J Obstet Gynecol. 2000;182:1233-1238.
3. Meagher S, Walker S, Choong S. Mid-trimester fetal subdural hemorrhage: prenatal diagnosis. Ultrasound Obstet Gynecol. 2002;20:296-298.
4. Hildebrandt T, Powell T. Repeated antenatal intracranial hemorrhage: magnetic resonance imaging in a fetus with alloimmune thrombocytopenia. Arch Dis Child Fetal Neonatal Ed. 2002;87:F222-F223.
5. Ouwehand W, Smith G, Ranasinghe E. Management of severe alloimmune thrombocytopenia in the newborn. Arch Dis Child Fetal Neonatal Ed. 2000;82: F173-F175.
6. Husebekk A, Jaegtvik S, Aune B, et al. Does anti-D protect platelets from anti HPA 1A mediated destruction? Br J Heamatol. 1999;106:835.
7. Gaddipati S, Berkowitz R, Richard L, et al. Initial fetal platelet counts predict the response to intravenous gammaglobulin therapy in fetuses that are affected by PLA1 incompatibility. Am J Obstet Gnyecol. 2001;185:976-980.
8. Curtis B, Ali S, Glazier A, et al. Isoimmunization against CD36 (glycoprotein IV): description of four cases of neonatal isoimmune thrombocytopenia and brief review of the literature. Transfusion. 2002;42:1173-1179.
9. Grainger J, Morrell G, Yates J, et al. Neonatal alloimmune thrombocytopenia with significant HLA antibodies. Arch Dis Child Fetal Neonatal Ed. 2002;86: F200-F201.
10. Lee K, Beaujean F, Bierling P. Treatment of severe fetomaternal alloimmune thrombocytopenia with compatible frozen-thawed platelet concentrates. Br J Haematol. 2002;117:482-483.
11. Clark A. Clinical uses of intravenous immunoglobulin in pregnancy. Clin Obstet Gynecol. 1999;42:368-380.
12. Skupski D, Bussel J. Alloimmune thrombocytopenia. Clin Obstet Gynecol. 1999;42:335-348.
13. Roberts I, Murray N. Management of thrombocytopenia in neonates. Br J Haematol. 1999;105:864-870.
14. Kjaer K, Jaegtvik S, Husebekk A, et al. Human platelet antigen 1 (HPA 1) genotyping with 5′ nuclease assay and sequence-specific primers reveals a single nucleotide deletion in intron 2 of the HPA 1a allele of platelet glycoprotein IIIa. Br J Haematol. 2002;117:405-408.
15. Bessos H, Thomson A, Wilson D, et al. Neonatal alloimmune thrombocytopenia in Scotland: a national HPA-1 epidemiological study involving 26 507 pregnant women. Br J Haematol. 2002;117:87-88.
16. Panzer S, Auerbach L, Cechova E, et al. Maternal alloimmunization against fetal platelet antigens: a prospective study. Br J Haematol. 1995;90:655-660.
17. Glade-Bender J, McFarland J, Kaplan C, et al. Anti HPA-3A induces severe neonatal alloimmune thrombocytopenia. J Pediatr. 2001;138:862-867.
18. Ohto H, Yamaguchi T, Takeuchi C, et al. Anti HPA-5b-induced neonatal alloimmune thrombocytopenia: antibody titer as a predictor. Br J Haematol. 2000;110:223-227.
19. a) as determined by antenatal screening. Blood. 1998;92:2280-2287.
20. Bussel J, Zabusky M, Berkowitz R, et al. Fetal alloimmune thrombocytopenia. Obstet Gynecol Surv. 1998;53:69-71.
21. Weber S, Hummel S, Weber A, et al. Genotyping of human platelet antigen-1 by gene amplification and labeling in one system and automated fluorescence correlation spectroscopy. Br J Haematol. 2002;116:839-843.
22. Hurd C, Cavanagh G, Schuh A, et al. Genotyping for platelet-specific antigens: techniques for the detection of single nucleotide polymorphisms. Vox Sang. 2002;83:1-12.
23. Roberts I, Murray N. Neonatal thrombocytopenia: new insights into pathogenesis and implications for clinical management. Curr Opin Pediatr. 2001;13:16-21.
24. Davoren A, McParland P, Barnes C, et al. Neonatal alloimmune thrombocytopenia in the Irish population: a discrepancy between observed and expected cases. J Clin Pathol. 2002;55:289-292.
25. Radder C, Brand A, Kanhai H. A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol. 2001;185:683-688.
26. Bussel J, Zabusky M, Berkowitz R, et al. Fetal alloimmune thrombocytopenia. N Engl J Med. 1997;337: 22-26.
27. Hessner M, Agostini T, Bellissimo D, et al. The sensitivity of allele-specific polymerase chain reaction can obviate concern of maternal contamination when fetal samples are genotyped for immune cytopenic disorders. Am J Obstet Gynecol. 1997;176:327-333.
28. Rodeck C, Roberts L. Successful treatment of fetal cardiac arrest by left ventricular exchange transfusion. Fetal Diagn Ther. 1994;9:213-217.
29. Branch D, Porter T, Paidas M, et al. Obstetric uses of intravenous immunoglobulin: successes, failures and promises. J Allergy Clin Immunol. 2001;108:S133-S138.